Variables Mean of difference 95%CI P- value
Raloxifene/experimental N=18 Placebo/control N=19
BMI(Kg/m2) 0.13 ± 0.68 0.06 ± 0.84 -0.61_0.49 0.818
SBP(mmHg) -9.1 ± 19.8 -9 ± 22.7 -15.4_15.4 1
DBP(mmHg) -5.3 ± 9.2 1.5 ± 8.1 -0.6_13.1 0.051
HbA1C(mg/dL) -0.05 ± 2.09 -0.34 ± 1.87 -1.72_1.15 0.685
TG(mg/dL) 31.9 ± 99.8 -2.2 ± 81.6 -99.9_31.7 0.299
Chol(mg/dL) 61.4 -1.8 ± 26.6 -27_41.3 0.673
HDL(mg/dL) 6.8 ± 47 2.4 ± 6.5 -1.6_6.8 0.223
LDL(mg/dL) 6.8 ± 47 -2.5 ± 26.7 18.7_-37.2 0.5
ACR(μg/mg) -339.9 ± 1173.2 260.2 ± 606.6 -73.4_1273.4 0.0041
ACR log -0.53 0.03 0.0104-0.968 0.0451
GFR(ml/min) -2.4 ± 7.7 -1.5 ± 5.6 -3.9_5.8 0.706
1-P value< 0.05 is considered statistically significant
BMI: Body Mass Index; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; TG: Triglyceride; Chol: Cholesterol; HDL: High Density Lipoprotein; LDL: Low Density Lipoprotein; ACR: Albumin to Creatinin ratio; ACR log: Logarithm of ACR; GFR: Glomerular Filtration Rate
Table 4: Comparison between two groups of post menopausal diabetic women for their mean difference of clinical and biochemical parameters during the intervention.